Florence Thomas

1.6k total citations
26 papers, 1.2k citations indexed

About

Florence Thomas is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, Florence Thomas has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 9 papers in Surgery and 6 papers in Pharmacology. Recurrent topics in Florence Thomas's work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (16 papers) and Genital Health and Disease (8 papers). Florence Thomas is often cited by papers focused on Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (16 papers) and Genital Health and Disease (8 papers). Florence Thomas collaborates with scholars based in Belgium, France and Germany. Florence Thomas's co-authors include Corinne Hanotin, E. Leutenegger, P Vague, Olivier Ziegler, M Apfelbaum, Dominique Descamps, Tino F. Schwarz, P.V. Suryakiran, Frank Struyf and Pierre Drouin and has published in prestigious journals such as The American Journal of Medicine, The Journal of Infectious Diseases and International Journal of Cancer.

In The Last Decade

Florence Thomas

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Thomas Belgium 19 677 348 275 175 172 26 1.2k
J Prandota Poland 17 403 0.6× 108 0.3× 60 0.2× 78 0.4× 63 0.4× 61 1.2k
Derek M. Culnan United States 12 149 0.2× 31 0.1× 210 0.8× 153 0.9× 92 0.5× 21 781
Martin H. Ulshen United States 18 136 0.2× 33 0.1× 482 1.8× 142 0.8× 47 0.3× 59 1.6k
Kerry Mills Australia 16 334 0.5× 18 0.1× 60 0.2× 204 1.2× 109 0.6× 28 1.0k
Pei‐Ying Wu Taiwan 21 333 0.5× 36 0.1× 49 0.2× 213 1.2× 26 0.2× 76 1.2k
Cong Chen China 15 134 0.2× 53 0.2× 92 0.3× 39 0.2× 34 0.2× 54 1.1k
Charles Brummitt United States 15 261 0.4× 83 0.2× 99 0.4× 60 0.3× 70 0.4× 28 928
Mohammad‐Ali Jenabian Canada 22 282 0.4× 157 0.5× 71 0.3× 38 0.2× 328 1.9× 66 1.2k
Patrick Behrendt Germany 20 413 0.6× 25 0.1× 42 0.2× 56 0.3× 164 1.0× 62 1.5k
Eelke Brandsma Netherlands 8 130 0.2× 29 0.1× 96 0.3× 403 2.3× 98 0.6× 13 1.1k

Countries citing papers authored by Florence Thomas

Since Specialization
Citations

This map shows the geographic impact of Florence Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Thomas more than expected).

Fields of papers citing papers by Florence Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Thomas. The network helps show where Florence Thomas may publish in the future.

Co-authorship network of co-authors of Florence Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Thomas. A scholar is included among the top collaborators of Florence Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Thomas. Florence Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Romanowski, Barbara, Tino F. Schwarz, Linda Ferguson, et al.. (2015). Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study. Human Vaccines & Immunotherapeutics. 12(1). 20–29. 70 indexed citations
3.
4.
Romanowski, Barbara, Tino F. Schwarz, Linda M. Ferguson, et al.. (2014). Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination. Human Vaccines & Immunotherapeutics. 10(5). 1155–1165. 85 indexed citations
5.
Boxus, Mathieu, et al.. (2014). Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule. Vaccine. 32(26). 3232–3236. 31 indexed citations
6.
Denny, Lynette, Florence Thomas, Marjan Hezareh, et al.. (2013). Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study. Vaccine. 31(48). 5745–5753. 79 indexed citations
7.
Schwarz, Tino F., Li‐Min Huang, Alejandra Valencia, et al.. (2012). Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years. Journal of Adolescent Health. 50(2). 187–194. 49 indexed citations
8.
Sow, Papa Salif, Deborah Watson‐Jones, Nancy B. Kiviat, et al.. (2012). Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women. The Journal of Infectious Diseases. 207(11). 1753–1763. 52 indexed citations
9.
Schwarz, Tino F., Barbara Romanowski, Klaus Peters, et al.. (2012). O608 IMMUNE RESPONSE TO THE HPV‐16/18 AS04‐ADJUVANTED VACCINE ADMINISTERED AS A 2‐DOSE OR 3‐DOSE SCHEDULE UP TO 3 YEARS AFTER VACCINATION. International Journal of Gynecology & Obstetrics. 119(S3). 2 indexed citations
10.
Schwarz, Tino F., Marek Spaczyński, Achim Schneider, et al.. (2011). Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years. Human Vaccines. 7(9). 958–965. 33 indexed citations
11.
Esposito, Susanna, Victoria Bîrluțiu, Pavol Jarčuška, et al.. (2011). Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine Administered According to an Alternative Dosing Schedule Compared With the Standard Dosing Schedule in Healthy Women Aged 15 to 25 Years. The Pediatric Infectious Disease Journal. 30(3). e49–e55. 28 indexed citations
12.
Petäjä, Tiina, Court Pedersen, Airi Põder, et al.. (2010). Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women. International Journal of Cancer. 129(9). 2147–2157. 73 indexed citations
13.
14.
Schwarz, Tino F., José García-Sicilia, Alfonso Carmona, et al.. (2008). Co-Administration of GSK's AS04 Adjuvanted Cervical Cancer Vaccine with Combined dTpa-IPV Vaccine in Girls Aged 10–18 Years. International Journal of Infectious Diseases. 12. e150–e150. 2 indexed citations
15.
Checchi, Francesco, et al.. (2007). Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series. PLoS neglected tropical diseases. 1(2). e64–e64. 47 indexed citations
16.
Chapelot, Didier, Corinne Marmonier, Florence Thomas, & Corinne Hanotin. (2000). Modalities of the food intake-reducing effect of sibutramine in humans. Physiology & Behavior. 68(3). 299–308. 32 indexed citations
17.
Apfelbaum, M, P Vague, Olivier Ziegler, et al.. (1999). Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. The American Journal of Medicine. 106(2). 179–184. 263 indexed citations
18.
Hanotin, Corinne, Florence Thomas, Stephen P. Jones, E. Leutenegger, & Pierre Drouin. (1998). A Comparison of Sibutramine and Dexfenfluramine in the Treatment of Obesity. Obesity Research. 6(4). 285–291. 32 indexed citations
19.
Hanotin, Corinne, et al.. (1997). Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study. International Journal of Obesity. 22(1). 32–38. 78 indexed citations
20.
Dreiser, R.-L., et al.. (1994). Flurbiprofen local action transcutaneous (LAT): clinical evaluation in the treatment of acute ankle sprains.. PubMed. 14(4). 9–13. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Prandota Breakdown of academic impact, for papers by Derek M. Culnan Breakdown of academic impact, for papers by Martin H. Ulshen Breakdown of academic impact, for papers by Kerry Mills Breakdown of academic impact, for papers by Pei‐Ying Wu Breakdown of academic impact, for papers by Cong Chen Breakdown of academic impact, for papers by Charles Brummitt Breakdown of academic impact, for papers by Mohammad‐Ali Jenabian Breakdown of academic impact, for papers by Patrick Behrendt Breakdown of academic impact, for papers by Eelke Brandsma
Rankless by CCL
2026